CYP-LAD
CYP-LAD, also known as 6-cyclopropyl-6-nor-lysergic acid diethylamide or as TRALA-22, is a lysergamide and analogue of lysergic acid diethylamide. It was patented by Daniel Trachsel and colleagues in 2023 as an LSD analogue with modified LSD-like action, and had also previously been claimed in a 2022 patent by Gilgamesh Pharmaceuticals.